Our Featured Experts

Julie R. Brahmer, MD
Dr. Brahmer on Impact of CheckMate-057 in NSCLC
Julie R. Brahmer, MD, interim director, Sidney Kimmel Comprehensive Cancer Center, associate professor of oncology, Johns Hopkins Medicine, discusses how the CheckMate-057 trial could impact the treatment of non-small cell lung cancer (NSCLC).
Corey J. Langer, MD
Oncology Specialists
Publication Bottom Border
Border Publication
x